Publicaciones en las que colabora con MONTSERRAT MARTINEZ ALONSO (20)

2021

  1. Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1043-1054

2019

  1. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  2. Lung function measurements in the prediabetes stage: data from the ILERVAS Project

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012

  3. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project

    Diabetes and Metabolism

2018

  1. Predictors of long-term adherence to continuous positive airway pressure in patients with obstructive sleep apnoea and acute coronary syndrome

    Journal of Thoracic Disease, Vol. 10, pp. S124-S134

  2. Rationale and Methodology of the SARAH Trial: Long-Term Cardiovascular Outcomes in Patients With Resistant Hypertension and Obstructive Sleep Apnea

    Archivos de Bronconeumologia, Vol. 54, Núm. 10, pp. 518-523

2017

  1. Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: The predictive value of 24-h ambulatory blood pressure monitoring

    European Respiratory Journal, Vol. 50, Núm. 4

  2. Sleep Apnea and Hypertension: Are There Sex Differences? The Vitoria Sleep Cohort

    Chest, Vol. 152, Núm. 4, pp. 742-750

2016

  1. Long-term adherence to continuous positive airway pressure therapy in non-sleepy sleep apnea patients

    Sleep Medicine, Vol. 17, pp. 1-6

  2. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia, Vol. 36, Núm. 4, pp. 389-396

  3. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 36, Núm. 4, pp. 389-396

2015

  1. Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea Blood Pressure Response to Continuous Positive Airway Pressure Treatment

    Journal of the American College of Cardiology, Vol. 66, Núm. 9, pp. 1023-1032

  2. Use of Ambulatory Blood Pressure Monitoring for the Screening of Obstructive Sleep Apnea

    Journal of Clinical Hypertension, Vol. 17, Núm. 10, pp. 802-809

2014

  1. Obstructive sleep apnea is associated with cancer mortality in younger patients

    Sleep Medicine, Vol. 15, Núm. 7, pp. 742-748

2013

  1. Rationale and methodology of the impact of continuous positive airway pressure on patients with ACS and nonsleepy OSA: The ISAACC trial

    Clinical Cardiology, Vol. 36, Núm. 9, pp. 495-501

  2. The relationship between floppy eyelid syndrome and obstructive sleep apnoea

    British Journal of Ophthalmology, Vol. 97, Núm. 11, pp. 1387-1390

2012

  1. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: A randomized controlled trial

    JAMA - Journal of the American Medical Association, Vol. 307, Núm. 20, pp. 2161-2168

2011

  1. Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea

    Sleep and Breathing, Vol. 15, Núm. 3, pp. 403-408

  2. Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea

    Respiratory Medicine, Vol. 105, Núm. 12, pp. 1954-1960

2010

  1. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea

    American Journal of Respiratory and Critical Care Medicine, Vol. 181, Núm. 7, pp. 718-726